| 000 | 01591 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518041605.0 | ||
| 264 | 0 | _c20200401 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/CIRCULATIONAHA.118.037398 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrysyazhna, Oleksandra | |
| 245 | 0 | 0 |
_aBlood Pressure-Lowering by the Antioxidant Resveratrol Is Counterintuitively Mediated by Oxidation of cGMP-Dependent Protein Kinase. _h[electronic resource] |
| 260 |
_bCirculation _c07 2019 |
||
| 300 |
_a126-137 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCyclic GMP-Dependent Protein Kinase Type I _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 | _aOrgan Culture Techniques |
| 650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aResveratrol _xpharmacology |
| 650 | 0 | 4 |
_aTelemetry _xmethods |
| 700 | 1 | _aWolhuter, Kathryn | |
| 700 | 1 | _aSwitzer, Christopher | |
| 700 | 1 | _aSantos, Celio | |
| 700 | 1 | _aYang, Xiaoping | |
| 700 | 1 | _aLynham, Steven | |
| 700 | 1 | _aShah, Ajay M | |
| 700 | 1 | _aEaton, Philip | |
| 700 | 1 | _aBurgoyne, Joseph R | |
| 773 | 0 |
_tCirculation _gvol. 140 _gno. 2 _gp. 126-137 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCULATIONAHA.118.037398 _zAvailable from publisher's website |
| 999 |
_c29717903 _d29717903 |
||